Invokana: first sodium-glucose co-transporter 2 inhibitor for type 2 diabetesReduces plasma glucose by decreasing renal reabsorption and increasing urinary excretion of glucose. Press Review – May 26, 2014 Europe: Pharmacy's closure exposes holes in U.K. care home supply Drugstores scramble to fill void left by bankruptcy of Pharmacy Plus. Fentanyl scam uncovered in Ontario Health centre receptionist sentenced to nine years would verify forged prescriptions when pharmacies called to double-check orders. Stateside: New video helps identify those who abuse prescription drugs Production titled Red Flags was unveiled earlier this month. OPA urges members to support parties that share profession’s vision Association puts forward three priorities to promote to all party candidates. Specialty drug spend unsustainable Spending on specialty drugs is likely to increase at a significant rate, substantially impacting the cost employers pay, according to a report. Stateside: Witness a pharmacist union in action Group in row with insurer and pharmacy operator over pensions, rushed patient interactions. Are you ready for change? These proven steps can help staff embrace new ways of providing services London fertility doctor suspended after professional misconduct Updated Canadian statement on herpes zoster vaccine C. difficile: Waging a difficult battle Concerns and current issues in prevention and treatment of clostridium difficile infection. First Previous 678 679 680 681 682 Next Last
